NCT07449728

Brief Summary

Technically successful laser crossectomy will reduce the risk of reflux recurrence at the sapheno-femoral junction without increasing the risk of endovenous heat-induced thrombosis, which may positively impact the likelihood of ultrasound- or clinical-recurrence of varicose veins. Similar technical efficacy is expected for laser crossectomy at 1940 nm and 1470 nm. A possible advantage of the 1940 nm wavelength in terms of postoperative pain intensity and the risk of adverse events cannot be ruled out.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
30mo left

Started Jan 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Jan 2026Jan 2029

Study Start

First participant enrolled

January 20, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 26, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 4, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2029

Last Updated

March 4, 2026

Status Verified

February 1, 2026

Enrollment Period

2 years

First QC Date

February 26, 2026

Last Update Submit

February 26, 2026

Conditions

Keywords

Varicose veinsEndovenous laser treatmentRefluxRecurrenceCrossectomy

Outcome Measures

Primary Outcomes (1)

  • Number of patients with reflux recurrence at the sapheno-femoral junction

    Defined as the presence of reflux, with a duration of \>0.5 sec under provocation manoeuvre (Valsalva manoeuvre and/or manual distal compression), at the zone of treated SFJ, including reflux on recanalized GSV trunk, on the AASV or any other tributaries, on the lymph node venous network, on the inguinal or perineal veins as detected by duplex ultrasound scan (DUS).

    12 months

Secondary Outcomes (9)

  • Number of patients with technically possible laser crossectomy

    0 days

  • Number of patients with technically successful laser crossectomy

    3 days

  • Length of GSV stump

    12 months

  • Number of patients with EHIT of 2-4 classes

    12 months

  • Number of patients with GSV recanalization

    12 months

  • +4 more secondary outcomes

Study Arms (3)

Group 1 (1470 nm)

EXPERIMENTAL

Laser crossectomy will be performed with a wavelength of 1470 nm and radial fiber with a core diameter of 0.4 mm and a bulb diameter of 1.57 mm at a power of 6-8 W by manual extraction at a speed of 1 mm/s (LED of 60-80 J/cm). EVLT of the great saphenous vein (GSV) trunk will be performed with a standard approach.

Procedure: Laser crossectomy on 1470 nm

Group 2 (1940 nm)

EXPERIMENTAL

Laser crossectomy will be performed with a wavelength of 1940 nm and radial fiber with a core diameter of 0.55 mm and a bulb diameter of 1.4 mm at a power of 4-6 W by manual extraction at a speed of 1 mm/s (LED of 40-60 J/cm). EVLT of the GSV trunk will be performed with a standard approach.

Procedure: Laser crossectomy on 1940 nm

Control

ACTIVE COMPARATOR

Will contain patients who have failed to perform laser crossectomy at 1470 nm or 1940 nm wavelength due to technical impossibility or technical failure, and underwent EVLT of the GSV trunk with preservation of the stump.

Procedure: Standard EVLT with a stump

Interventions

Attempt to perform laser crossectomy with radial fiber (core of 0.4 mm, bulb of 1.57 mm) on the 1470 nm wavelength laser with a power of 6-8 W and an LED of 60-80 J/cm. Performing the GSV trunk ablation according to the indications.

Group 1 (1470 nm)

Attempt to perform laser crossectomy with radial fiber (core of 0.55 mm, bulb of 1.4 mm) on the 1940 nm wavelength laser with a power of 4-6 W and an LED of 40-60 J/cm. Performing the GSV trunk ablation according to the indications.

Group 2 (1940 nm)

Attempted laser crossectomy on 1470 nm or 1940 nm failed due to anatomical features of the SFJ or technical reasons, and the GSV trunk was obliterated with persistence of the stump.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years
  • Primary VVs of Clinical Etiology Anatomy Pathophysiology (CEAP) clinical class of C2-C6
  • Reflux along the GSV trunk lasting \>0.5 sec.
  • GSV trunk diameter ≤12 mm
  • Informed consent to participate in the study

You may not qualify if:

  • Primary reflux outside the GSV trunk (including combined reflux)
  • History of deep or superficial vein thrombosis
  • Deep vein reflux
  • Non-thrombotic or post-thrombotic venous obstruction
  • Pelvic venous insufficiency
  • Use of oral anticoagulants
  • Indication for pharmacological prophylaxis after EVLT
  • Inability to use radial fiber of 1.4-1.57 mm at the surgeon's discretion
  • Refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MedSwiss Private Cinic

Moscow, 143082, Russia

RECRUITING

MeSH Terms

Conditions

Varicose VeinsGastroesophageal RefluxRecurrence

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesEsophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Kirill Lobastov, PhD

    Pirogov Russian National Research Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kirill Lobastov, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: An open-label pragmatic randomized controlled trial with 3 parallel groups, where allocation into two experimental groups is performed randomly (wavelength of 1470 or 1940 nm), and the third control group contains subjects for whom a laser crossectomy was technically impossible or failed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of the Department of General surgery named after V.M. Buyanov

Study Record Dates

First Submitted

February 26, 2026

First Posted

March 4, 2026

Study Start

January 20, 2026

Primary Completion (Estimated)

January 20, 2028

Study Completion (Estimated)

January 20, 2029

Last Updated

March 4, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations